Acute Lymphoblastic Leukemia News and Research

RSS
Acute lymphoblastic leukemia (ALL) is a cancer of the white blood cells, the cells in the body that normally fight infections. There are two main types of white blood cells-lymphoid cells and myeloid cells. ALL affects lymphoid cells.
New CAR-T cell therapy offers effective option for certain blood cancer patients

New CAR-T cell therapy offers effective option for certain blood cancer patients

Cascade of costs could push new gene therapy above $1 million per patient

Cascade of costs could push new gene therapy above $1 million per patient

Study provides detailed characterization of neurotoxicity arising from CD19 CAR T-cell therapy

Study provides detailed characterization of neurotoxicity arising from CD19 CAR T-cell therapy

BU professor receives $792,000 grant to study about aggressiveness of T-ALL

BU professor receives $792,000 grant to study about aggressiveness of T-ALL

Researchers identify new cancer-causing pathway behind most aggressive type of leukemia

Researchers identify new cancer-causing pathway behind most aggressive type of leukemia

New gene therapy to treat cancer in children, young adults offers hopes and challenges

New gene therapy to treat cancer in children, young adults offers hopes and challenges

Diet and exercise have potential to improve chemotherapy effectiveness in pediatric cancer patients

Diet and exercise have potential to improve chemotherapy effectiveness in pediatric cancer patients

Inactivation of Capicua gene leads to formation of T-ALL tumors in mice, researchers find

Inactivation of Capicua gene leads to formation of T-ALL tumors in mice, researchers find

Spot Leukaemia campaign launched to reduce delays in diagnosis

Spot Leukaemia campaign launched to reduce delays in diagnosis

UChicago Medicine working with Novartis to offer breakthrough gene therapy for pediatric ALL patients

UChicago Medicine working with Novartis to offer breakthrough gene therapy for pediatric ALL patients

FDA makes the first gene therapy Kymriah available for treatment of pediatric ALL

FDA makes the first gene therapy Kymriah available for treatment of pediatric ALL

Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL

Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL

Pioneering cancer gene therapy gets green light — and $475,000 price tag

Pioneering cancer gene therapy gets green light — and $475,000 price tag

FDA approves first cell-based gene therapy for use in the United States

FDA approves first cell-based gene therapy for use in the United States

FDA approves Besponsa – Pfizer’s new drug for rare form of acute lymphoblastic leukemia

FDA approves Besponsa – Pfizer’s new drug for rare form of acute lymphoblastic leukemia

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

New analysis compares emerging algorithms that look for cancer mutations

New analysis compares emerging algorithms that look for cancer mutations

FDA panel recommends new breakthrough gene therapy for B-cell acute lymphoblastic leukemia (ALL)

FDA panel recommends new breakthrough gene therapy for B-cell acute lymphoblastic leukemia (ALL)

ERYTECH partners with Queen’s University to advance its product candidate for treating arginase-1 deficiency

ERYTECH partners with Queen’s University to advance its product candidate for treating arginase-1 deficiency